The story · written by gpt-6,
Greenland tightened the conditions for its low-THC cannabis exception in April 2024, requiring imports in batches for distribution through storage controlled by the authorised importer.[1] The replacement rules took effect on 22 April and also required documentation identifying products and showing that they met the 0.2% THC ceiling.[1]
The earlier exception linked products to import permission
Since January 2023, the drug-control regulation had excluded qualifying cannabis products from its controlled-drug definition when they contained no more than 0.2% THC and were imported by an authorised legal entity, such as a company.[2] The Chief Medical Officer’s office could grant import permission and attach conditions.[2]
That route followed parliament’s 2019 calls for Greenlandic access to low-THC cannabis products and oils.[3] A local law was needed because responsibility for drug legislation had passed to Greenland with health services in 1992.[3]
Storage and distribution became part of the test
The April regulation retained the THC ceiling and authorised-importer requirement.[1] It added that the goods must be imported in batches for distribution after arriving at storage or similar premises in Greenland controlled by the importer.[1]
Applicants had to provide information making the substance identifiable as part of a clearly described product and document compliance with the THC ceiling.[1] Permission remained restricted to legal entities, and the importer remained responsible for the products meeting that limit.[1]
The regulation also applied its rules to import applications that had not been decided when it took effect.[1] This brought pending applications under the replacement conditions.[1]
Controlled medicines followed their own permissions
Greenland’s drug law separately permitted pharmacy handling and receipt of controlled medicines under prescription rules.[4] The regulation provided permissions for patients, treatment settings and authorised institutions, while otherwise limiting controlled drugs to medical and scientific use.[1]
Cultivation and manufacture of controlled drugs had to follow the medicines rules, including safeguards against unauthorised access and removal.[1] Those requirements operated alongside the exception for qualifying imported low-THC products.[1]
The conditions continue in the current rules
The current drug-control regulation retains the authorised-import, THC and local-distribution conditions.[5] For businesses seeking to use the exception, the route therefore involves both product documentation and permission for the organisation importing it.[5]
The government later emphasised customs controls and prevention in June 2026, including treatment and support for families and young people.[6] Those policies sit alongside the low-THC route described in Greenland’s profile.[5][6]
Listed for context. No score change is recorded for Greenland here.
References
- Greenland — Drug-control regulation 16 of 20 April 2024Sections 1(4), 9 and 19; effective 22 April 2024; signed 19 Aprilarchived
- Greenland — Drug-control regulation 40 of 23 December 2022Sections 1(4), 3–5, 9 and 19; effective 1 January 2023archived
- Naalakkersuisut — Explanatory notes to the local drug-law bill, 17 August 2022pp. 1–3: inherited law, 1992 competence, 2019 parliamentary decisions and authority for low-THC rulesarchived
- Greenland — Inatsisartut Act 24 of 25 November 2022 on euphoriant substancesSections 1–7; effective 1 January 2023archived
- Greenland — Current drug-control regulation 61 of 1 September 2025Sections 1–18; signature dated 22 August; publication and commencement distinguishedarchived
- Naalakkersuisut — Response to the debate proposal on preventing hash misuse, FM 2026/144 (1 June 2026)archived
Checked. The date and the event were compared with a source that was read.